An electronic diary is shown to be more reliable than a paper diary: Results from a randomized crossover study in patients with persistent asthma

Journal of Asthma

Volumn 49, Issue 9, 2012, Pages 952-960

  Ireland, Andrea M ^a   Wiklund, Ingela ^a   Hsieh, Ray ^a   Dale, Peter ^b   O'Rourke, Erin ^a  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma; Crossover design; Electronic devices; Patient reported outcomes; Symptoms

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; STEROID;

ADULT; ARTICLE; ASTHMA; ASTHMATIC STATE; CROSSOVER PROCEDURE; DISEASE CONTROL; ELECTRONIC DIARY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INFORMATION SYSTEM; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; QUESTIONNAIRE; REPRODUCIBILITY; TEST RETEST RELIABILITY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; ASTHMA; CHILD; CROSS-OVER STUDIES; DATA COLLECTION; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SELF REPORT; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84867549917     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2012.724754     Document Type: Article

References (31)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2011. Available at: Http://www.ginasthma.org/ guidelines-gina-report-global-strategy-for-asthma.html. Accessed May 17, 2012
2. Lemanske Jr RF, Busse WW. Asthma: Clinical expression and molecular mechanisms. J Allergy Clin Immunol 2010; 125:S95-S102
3. Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Szefler SJ, Sullivan SD, Thomas MD, Wenzel SE, Reddel HK. A new perspective on concepts of asthma severity and control. Eur Respir J 2008; 32:545-554
4. Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999; 2:113-127
5. Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal recall periods for patient-reported outcomes: Challenges and potential solutions. Curr Med Res Opin 2009; 25:929-942
6. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. An official American Thoracic Society/ European Respiratory Society statement: Asthma control and exacerbations. Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99
7. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with paper diaries. BMJ 2002; 324:1193-1194
8. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997; 10:646-651
9. Wyrwich KW, Ireland AM, Navaratnam P, Nolte H, Gates Jr DF. Validation of the AQLQ12θ among adolescents and adults with persistent asthma. Qual Life Res 2011; 20:903-912
10. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: A meta-analytic review. Value Health 2008; 11:322-333
11. Jiang H, Han J, Zhu Z, Xu W, Zheng J, Zhu Y. Patient compliance with assessing and monitoring of asthma. J Asthma 2009; 46:1027-1031
12. Meltzer EO, Kelley N, Hovell MF. Randomized, cross-over evaluation of mobile phone vs paper diary in subjects with mild to moderate persistent asthma. Open Respir Med J 2008; 2:72-79
13. Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health 2009; 12:419-429
14. Food and Drug Administration (FDA). Guidance for industry on patient-reported outcome measures: Use in medical product development to support labeling claims. Federal Register 2009; 74: 65132-65133
15. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136:225-244
16. National Heart, Lung, and Blood Institute (NHLBI). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program. Bethesda, MD: National Heart, Lung, and Blood Institute (NHLBI), 2007
17. Kosinski M, Kite A, Yang M, Rosenzweig JC, Williams A. Comparability of the Asthma Control Test telephone interview administration format with self-administered mail-out mail-back format. Curr Med Res Opin 2009; 25:717-727
18. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: A survey for assessing asthma control. J Allergy Clin Immunol 2004; 113:59-65
19. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005; 26:319-338
20. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117:549-556
21. Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol 2009; 124(719-723):e711
22. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10:407-415
23. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24:67-74
24. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother 2001; 35:997-1003
25. Ivanova JI, Birnbaum HG, Hsieh M, Yu AP, Seal B, van der Molen T, Emani S, Rosiello RA, Colice GL. Adherence to inhaled corticosteroid use and local adverse events in persistent asthma. Am J Manag Care 2008; 14:801-809
26. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population.AmJ Respir Crit Care Med 1999; 159:179-187
27. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. 1st ed. Oxford: Clarendon Press, 1994
28. Hays R, Revicki DA. Reliability and validity (including responsiveness). In: Fayers P, Hays R, eds. Assessing Quality of Life in Clinical Trials. New York: Oxford University Press, 2005: 25-39
29. Dinan MA, Compton KL, Dhillon JK, Hammill BG, Dewitt EM, Weinfurt KP, Schulman KA. Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials. Med Care 2011; 49:415-419
30. Committee for Medicinal Products for Human Use. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. London: European Medicines Agency, 2005
31. Kamper SJ, Maher CG, Mackay G. Global rating of change scales: A review of strengths and weaknesses and considerations for design. J Man Manip Ther 2009; 17:163-170